Why did FCG.AX stock spike in pre-market volume?

The spike to **1.18M** shares likely reflects fresh buying interest or news flow into the small‑cap healthcare name. Large relative volume often follows repositioning by traders, sector flows, or company updates, increasing short‑term volatility for FCG.AX stock.

What are the key support and resistance levels for FCG.AX stock?

Immediate support sits near **A$0.04** and resistance near **A$0.06**. A break above the **200‑day average at A$0.11** would be a stronger bullish signal for FCG.AX stock, given the current volume backdrop.

How does Meyka AI rate FCG.AX stock and why?

Meyka AI rates FCG.AX **65.79/100 (Grade B, HOLD)**. The grade balances cheap valuation metrics against micro‑cap liquidity risk, sector comparison, and forecast uncertainty, so the platform recommends monitoring catalysts and risk controls.

What is the Meyka AI forecast for FCG.AX stock?

Meyka AI's forecast model projects a near‑term target of **A$0.06**, versus the current **A$0.04**, implying a **50.00%** upside. Forecasts are model‑based projections and not guarantees.

AU Stocks

Volume 1.18M pre-market: FCG.AX Freedom Care Group (ASX) surge, key levels

ByDanny Kontos February 6, 2026

A sharp pre-market volume spike put FCG.AX stock in focus this morning. Volume at 1.18M shares is roughly 39.42x the 30‑day average, driving the price from the open of A$0.06 back toward the prior close at A$0.04. This early surge on the ASX suggests traders are re-evaluating Freedom Care Group Holdings Ltd. ahead of catalysts. We break down the volume drivers, valuation, technical levels and a model forecast to help frame short-term trading and medium-term risk.